CPX-351 improves survival following allogeneic hematopoietic cell transplant in older high-risk acute myeloid leukemia patients

(H. Lee Moffitt Cancer Center & Research Institute) Acute myeloid leukemia, or AML, is a type of cancer of the blood and bone marrow. It occurs most often in older populations and progresses rapidly, interfering with the production of red blood cells, white blood cells and platelets. Treatments include chemotherapy, drug therapy and stem-cell transplants.